The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

CVS Health Corporation (NYSE:CVS) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares. This forms part of the research note on the broader managed healthcare companies. The analyst highlighted that the firm expects significant embedded earnings potential that is associated with the ongoing margin recovery throughout the government businesses.

Furthermore, there are expectations of continued robust trends in the commercial business. The firm added that the Q1 medical cost trends were favourable to the consensus expectations of the analysts.

Notably, in Q1 2026, CVS Health Corporation (NYSE:CVS)’s total revenues came in at $100.4 billion, reflecting a rise of 6.2% YoY, with GAAP diluted EPS coming at $2.30 and adjusted EPS at $2.57. The company raised its FY 2026 guidance, with GAAP diluted EPS now expected to be between $6.24 – $6.44 compared to the previous range of $5.94 – $6.14.

CVS Health Corporation (NYSE:CVS) offers health solutions.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.